| http://dbpedia.org/ontology/abstract
|
Narnatumab is a human monoclonal antibody designed for the treatment of cancer. Clinical development was abandoned after phase I trials. Narnatumab was developed by ImClone Systems.
, نارناتوماب هو جسم مضاد وحيد النسيلة بشري مصمم لعلاج السرطان تطوره إمكلون (ImClone Systems).
|
| http://dbpedia.org/ontology/casNumber
|
1188275-92-4
|
| http://dbpedia.org/ontology/fdaUniiCode
|
R42YK40U9M
|
| http://dbpedia.org/ontology/kegg
|
D10074
|
| http://dbpedia.org/ontology/wikiPageID
|
33024085
|
| http://dbpedia.org/ontology/wikiPageLength
|
2162
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1002733548
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/ImClone_Systems +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/MST1R +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
6454
|
| http://dbpedia.org/property/casNumber
|
1188275
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
10026
|
| http://dbpedia.org/property/kegg
|
D10074
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/n
|
1754
|
| http://dbpedia.org/property/o
|
2020
|
| http://dbpedia.org/property/s
|
44
|
| http://dbpedia.org/property/source
|
o
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/MST1R +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
R42YK40U9M
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
458283354
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Narnatumab?oldid=1002733548&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Narnatumab +
|
| owl:sameAs |
http://ar.dbpedia.org/resource/%D9%86%D8%A7%D8%B1%D9%86%D8%A7%D8%AA%D9%88%D9%85%D8%A7%D8%A8 +
, http://dbpedia.org/resource/Narnatumab +
, http://rdf.freebase.com/ns/m.0h56dg8 +
, http://yago-knowledge.org/resource/Narnatumab +
, http://www.wikidata.org/entity/Q6966071 +
, https://global.dbpedia.org/id/4sJkv +
|
| rdf:type |
http://dbpedia.org/class/yago/Antibody115027189 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Narnatumab is a human monoclonal antibody designed for the treatment of cancer. Clinical development was abandoned after phase I trials. Narnatumab was developed by ImClone Systems.
, نارناتوماب هو جسم مضاد وحيد النسيلة بشري مصمم لعلاج السرطان تطوره إمكلون (ImClone Systems).
|
| rdfs:label |
Narnatumab
, نارناتوماب
|
